Identification of a novel ESR1 mutation in a Chinese PCOS woman with estrogen insensitivity in IVF treatment
Open Access
- 18 November 2022
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 20 (1) , 1-8
Abstract
Background: Polycystic ovary syndrome (PCOS) is a complex reproductive disorder, that affects approximately 5–10% of women of reproductive age. The disease is complex because its evolution may be impacted by genetic, lifestyle and environmental factors. Previous studies have emphasized the important roles of estrogen receptors in the pathogenesis of PCOS. Objective: To use whole exome sequencing (WES) to assess possible pathogenic factors in a PCOS patient who exhibited estrogen insensitivity during hormone replacement therapy (HRT) treatment. Methods: Genome sequencing and variant filtering via WES were performed in a patient with PCOS. DNA extraction from 364 unrelated female controls without PCOS was followed by PCR amplification, Sanger sequencing and sequence alignment. Evolutionary conservation analysis, protein structural modelling and in silico prediction were applied to analyse the potential pathogenicity of the novel ESR1 mutation. Result(s): During the controlled ovarian hyperstimulation (COH) period of an IVF cycle, the patient experienced markedly prolonged ovarian stimulation due to a poor response to gonadotropins (Gn) and elevated serum FSH. A novel heterozygous ESR1 mutation, c.619G > A/p.A207T, leading to the replacement of a highly conserved alanine with a threonine, was identified in this patient, via WES analysis. This novel variant was not identified in 364 unrelated female controls without PCOS, or in the Exome Aggregation Consortium (ExAC) or 1000 Genome Project. Conclusion(s): We identified a novel heterozygous ESR1 mutation in a Han Chinese PCOS woman exhibiting clinical signs of estrogen insensitivity. This study may provide new strategies for IVF therapy, especially for patients who exhibit estrogen insensitivity during IVF cycle.Keywords
All Related Versions
This publication has 29 references indexed in Scilit:
- Delayed Puberty and Estrogen Resistance in a Woman with Estrogen Receptor α VariantNew England Journal of Medicine, 2013
- Estrogen receptor α AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulatorsProceedings of the National Academy of Sciences, 2011
- Biological and biochemical consequences of global deletion of exon 3 from the ERα geneThe FASEB Journal, 2010
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteriaHuman Reproduction, 2009
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithmNature Protocols, 2009
- Factors Influencing Health Behaviors in the National Health and Nutritional Examination Survey, III (NHANES III)Social Work in Health Care, 2008
- Polycystic Ovary SyndromeNew England Journal of Medicine, 2005
- What pharmacologists can learn from recent advances in estrogen signallingTrends in Pharmacological Sciences, 2003
- Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a ManNew England Journal of Medicine, 1994